Hormone replacement therapy and life expectancy after prophylactic oophorectomy in women with BRCA1/2 mutations: a decision analysis

By  

The Women's Oncology Review, Vol. 4, Iss. 2, 2004-06 ,pp. : 115-116

Informa Healthcare

Access to resources Recommend Favorite

Estrogen Replacement Therapy Following Oophorectomy in Women with a Family History of Ovarian Cancer

By Eltabbakh G.H.   Piver M.S.   Hempling R.E.   Recio F.O.   Aiduk C.  

Gynecologic Oncology, Vol. 66, Iss. 1, 1997-07 ,pp. : 103-107

Elsevier

Access to resources Recommend Favorite

Factors affecting the decision to undergo risk-reducing salpingo-oophorectomy among women with BRCA gene mutation

By Kim Dongwon   Kang Eunyoung   Hwang Euijun   Sun Young   Hwang Yoonsun   Yom Cha   Kim Kidong   No Jae   Kim Yong-Beom   Kim Sung-Won  

Familial Cancer, Vol. 12, Iss. 4, 2013-12 ,pp. : 621-628

Springer Publishing Company

Access to resources Recommend Favorite

Decision Making about Prophylactic Oophorectomy among At-Risk Women: Psychological Influences and Implications

By Miller S.M.   Fang C.Y.   Manne S.L.   Engstrom P.F.   Daly M.B.  

Gynecologic Oncology, Vol. 75, Iss. 3, 1999-12 ,pp. : 406-412

Elsevier

Access to resources Recommend Favorite

Hormone Replacement Therapy after Breast Cancer?

By Burstein Harold J.  

Breast Cancer Research and Treatment, Vol. 81, Iss. 1, 2003-01 ,pp. : 99-101

Springer Publishing Company

Access to resources Recommend Favorite